261 related articles for article (PubMed ID: 19171113)
1. Atherosclerosis in autoimmune diseases.
Matsuura E; Kobayashi K; Lopez LR
Curr Rheumatol Rep; 2009 Feb; 11(1):61-9. PubMed ID: 19171113
[TBL] [Abstract][Full Text] [Related]
2. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome.
Matsuura E; Kobayashi K; Hurley BL; Lopez LR
Lupus; 2006; 15(7):478-83. PubMed ID: 16898186
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune-mediated atherothrombosis.
Matsuura E; Lopez LR
Lupus; 2008 Oct; 17(10):878-87. PubMed ID: 18827052
[TBL] [Abstract][Full Text] [Related]
4. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
Lopez LR; Simpson DF; Hurley BL; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
[TBL] [Abstract][Full Text] [Related]
5. Immunogenic oxidized low-density lipoprotein/beta2-glycoprotein I complexes in the diagnostic management of atherosclerosis.
Lopez LR; Kobayashi K; Matsunami Y; Matsuura E
Clin Rev Allergy Immunol; 2009 Aug; 37(1):12-9. PubMed ID: 18982458
[TBL] [Abstract][Full Text] [Related]
6. OxLDL/beta2GPI-anti-oxLDL/beta2GPI complex and atherosclerosis in SLE patients.
Bassi N; Ghirardello A; Iaccarino L; Zampieri S; Rampudda ME; Atzeni F; Sarzi-Puttini P; Shoenfeld Y; Doria A
Autoimmun Rev; 2007 Nov; 7(1):52-58. PubMed ID: 17967726
[TBL] [Abstract][Full Text] [Related]
7. Oxidized low-density lipoprotein and beta2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis.
Lopez LR; Salazar-Paramo M; Palafox-Sanchez C; Hurley BL; Matsuura E; Garcia-De La Torre I
Lupus; 2006; 15(2):80-6. PubMed ID: 16539278
[TBL] [Abstract][Full Text] [Related]
8. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis.
Matsuura E; Kobayashi K; Tabuchi M; Lopez LR
Prog Lipid Res; 2006 Nov; 45(6):466-86. PubMed ID: 16790279
[TBL] [Abstract][Full Text] [Related]
9. Atherogenic antiphospholipid antibodies in antiphospholipid syndrome.
Kobayashi K; Lopez LR; Matsuura E
Ann N Y Acad Sci; 2007 Jun; 1108():489-96. PubMed ID: 17894014
[TBL] [Abstract][Full Text] [Related]
10. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis.
Kobayashi K; Lopez LR; Shoenfeld Y; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():442-54. PubMed ID: 16126986
[TBL] [Abstract][Full Text] [Related]
11. Autoimmunity, infectious immunity, and atherosclerosis.
Matsuura E; Kobayashi K; Matsunami Y; Shen L; Quan N; Makarova M; Suchkov SV; Ayada K; Oguma K; Lopez LR
J Clin Immunol; 2009 Nov; 29(6):714-21. PubMed ID: 19795194
[TBL] [Abstract][Full Text] [Related]
12. Oxidized LDL/beta2-glycoprotein I complexes: new aspects in atherosclerosis.
Matsuura E; Kobayashi K; Inoue K; Lopez LR; Shoenfeld Y
Lupus; 2005; 14(9):736-41. PubMed ID: 16218478
[TBL] [Abstract][Full Text] [Related]
13. oxLDL/beta2GPI complex and anti-oxLDL/beta2GPI in SLE: prevalence and correlates.
Bassi N; Zampieri S; Ghirardello A; Tonon M; Zen M; Beggio S; Matsuura E; Doria A
Autoimmunity; 2009 May; 42(4):289-91. PubMed ID: 19811279
[TBL] [Abstract][Full Text] [Related]
14. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response.
Conti F; Spinelli FR; Alessandri C; Pacelli M; Ceccarelli F; Marocchi E; Montali A; Capozzi A; Buttari B; Profumo E; Sorice M; Arca M; Valesini G; Riganò R
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):661-8. PubMed ID: 24436371
[TBL] [Abstract][Full Text] [Related]
15. Oxidation of LDL and its clinical implication.
Matsuura E; Hughes GR; Khamashta MA
Autoimmun Rev; 2008 Jul; 7(7):558-66. PubMed ID: 18625445
[TBL] [Abstract][Full Text] [Related]
16. The immunology of atherothrombosis in the antiphospholipid syndrome: antigen presentation and lipid intracellular accumulation.
Matsuura E; Kobayashi K; Matsunami Y; Lopez LR
Autoimmun Rev; 2009 May; 8(6):500-5. PubMed ID: 19171205
[TBL] [Abstract][Full Text] [Related]
17. Arterial disease in lupus and secondary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein.
Romero FI; Amengual O; Atsumi T; Khamashta MA; Tinahones FJ; Hughes GR
Br J Rheumatol; 1998 Aug; 37(8):883-8. PubMed ID: 9734680
[TBL] [Abstract][Full Text] [Related]
18. Are oxidized LDL/beta2-glycoprotein I complexes pathogenic antigens in autoimmune-mediated atherosclerosis?
Matsuura E; Lopez LR
Clin Dev Immunol; 2004 Jun; 11(2):103-11. PubMed ID: 15330445
[TBL] [Abstract][Full Text] [Related]
19. Atherosclerosis-related markers in systemic lupus erythematosus patients: the role of humoral immunity in enhanced atherogenesis.
George J; Harats D; Gilburd B; Levy Y; Langevitz P; Shoenfeld Y
Lupus; 1999; 8(3):220-6. PubMed ID: 10342715
[TBL] [Abstract][Full Text] [Related]
20. IgG autoantibodies against beta2-glycoprotein I complexed with a lipid ligand derived from oxidized low-density lipoprotein are associated with arterial thrombosis in antiphospholipid syndrome.
Lopez D; Kobayashi K; Merrill JT; Matsuura E; Lopez LR
Clin Dev Immunol; 2003; 10(2-4):203-11. PubMed ID: 14768953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]